CirChem AB Shares Owned By Insiders vs. Revenue

CIRCHE Stock  SEK 2.99  0.03  1.01%   
Based on the measurements of profitability obtained from CirChem AB's financial statements, CirChem AB may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess CirChem AB's ability to earn profits and add value for shareholders.
For CirChem AB profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CirChem AB to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CirChem AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CirChem AB's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of CirChem AB over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between CirChem AB's value and its price as these two are different measures arrived at by different means. Investors typically determine if CirChem AB is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CirChem AB's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

CirChem AB Revenue vs. Shares Owned By Insiders Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining CirChem AB's current stock value. Our valuation model uses many indicators to compare CirChem AB value to that of its competitors to determine the firm's financial worth.
CirChem AB is number one stock in shares owned by insiders category among its peers. It also is the top company in revenue category among its peers totaling about  4,585  of Revenue per Shares Owned By Insiders. Comparative valuation analysis is a catch-all model that can be used if you cannot value CirChem AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CirChem AB's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

CirChem Revenue vs. Shares Owned By Insiders

Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

CirChem AB

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
18.66 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

CirChem AB

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
85.55 K
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

CirChem Revenue vs Competition

CirChem AB is the top company in revenue category among its peers. Market size based on revenue of Pollution & Treatment Controls industry is currently estimated at about 187.52 Million. CirChem AB adds roughly 85,553 in revenue claiming only tiny portion of equities listed under Pollution & Treatment Controls industry.

CirChem AB Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in CirChem AB, profitability is also one of the essential criteria for including it into their portfolios because, without profit, CirChem AB will eventually generate negative long term returns. The profitability progress is the general direction of CirChem AB's change in net profit over the period of time. It can combine multiple indicators of CirChem AB, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
CirChem AB engages in recycling of used solvents in Sweden. The company was founded in 2013 and is based in Vargon, Sweden. CirChem AB is traded on Stockholm Stock Exchange in Sweden.

CirChem Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on CirChem AB. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of CirChem AB position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the CirChem AB's important profitability drivers and their relationship over time.

Use CirChem AB in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CirChem AB position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CirChem AB will appreciate offsetting losses from the drop in the long position's value.

CirChem AB Pair Trading

CirChem AB Pair Trading Analysis

The ability to find closely correlated positions to CirChem AB could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CirChem AB when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CirChem AB - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CirChem AB to buy it.
The correlation of CirChem AB is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CirChem AB moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CirChem AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CirChem AB can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your CirChem AB position

In addition to having CirChem AB in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Strategy ETFs Thematic Idea Now

Strategy ETFs
Strategy ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Strategy ETFs theme has 1282 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Strategy ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in CirChem Stock

To fully project CirChem AB's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of CirChem AB at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include CirChem AB's income statement, its balance sheet, and the statement of cash flows.
Potential CirChem AB investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although CirChem AB investors may work on each financial statement separately, they are all related. The changes in CirChem AB's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on CirChem AB's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.